Predict your next investment

Other

See what CB Insights has to offer

Investments

4

About Junchenda Capital

Junchenda Capital is based in China.

Junchenda Capital Headquarter Location

Xiamen, Fujian,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Junchenda Capital Investments

4 Investments

Junchenda Capital has made 4 investments. Their latest investment was in Hrain Biotechnology as part of their Series B - II on September 9, 2020.

CBI Logo

Junchenda Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/8/2020

Series B - II

Hrain Biotechnology

$29.21M

No

Dongtai Chongye Biotechnology, E Fund, Hengzhen Biotechnology, Pudong Innotec, Sino-Sin Capital, Undisclosed Investors, Wanhui Capital, and Xinyi Capital

4

7/6/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

4/3/2020

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

9/30/2019

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/8/2020

7/6/2020

4/3/2020

9/30/2019

Round

Series B - II

Series B

Series B - II

Series B

Company

Hrain Biotechnology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$29.21M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Dongtai Chongye Biotechnology, E Fund, Hengzhen Biotechnology, Pudong Innotec, Sino-Sin Capital, Undisclosed Investors, Wanhui Capital, and Xinyi Capital

Sources

4

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.